Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H V Marquart

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Scandinavian Journal of Rheumatology|April 7, 2016
Polymyositis following autologous haematopoietic stem cell transplantationG Hedermann, H V Marquart, J Vissing
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1994
CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytesH V Marquart, S E Svehag, R G Leslie
Immunology|July 1, 1997
Complement-activating ability of leucocytes from patients with complement factor I deficiencyH V Marquart, J M Rasmussen, R G Leslie
Scandinavian Journal of Immunology|May 26, 2017
Case Report: Renal Transplantation in Patients with Pre-existing HypogammaglobulinemiaK P Lund, H Bruunsgaard, H V Marquart, et al.
Journal of Clinical Immunology|May 8, 2013
Long-term follow-up on affinity maturation and memory B-cell generation in patients with common variable immunodeficiencyV Ballegaard, H Permin, T L Katzenstein, et al.
Scandinavian Journal of Immunology|August 1, 1994
Interactions of opsonized immune complexes with whole blood cells: binding to erythrocytes restricts complex uptake by leucocyte populationsC H Nielsen, S E Svehag, H V Marquart, et al.
Immunology|March 20, 2002
CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytesC H Nielsen, H V Marquart, W M Prodinger, et al.
Complement (Basel, Switzerland)|January 1, 1988
Quantification of C3dg/Epstein-Barr virus receptors on human B cells and B cell linesJ M Rasmussen, H V Marquart, R Rask, et al.
Scandinavian Journal of Immunology|October 7, 1997
A comparative study of normal B cells and the EBV-positive Burkitt's lymphoma cell line, Raji, as activators of the complement systemH V Marquart, E H Olesen, A A Johnson, et al.
Clinical and Experimental Immunology|December 1, 1995
Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL)H V Marquart, K Grønbaek, B E Christensen, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Scandinavian Journal of Rheumatology|April 7, 2016
Polymyositis following autologous haematopoietic stem cell transplantationG Hedermann, H V Marquart, J Vissing
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1994
CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytesH V Marquart, S E Svehag, R G Leslie
Immunology|July 1, 1997
Complement-activating ability of leucocytes from patients with complement factor I deficiencyH V Marquart, J M Rasmussen, R G Leslie
Scandinavian Journal of Immunology|May 26, 2017
Case Report: Renal Transplantation in Patients with Pre-existing HypogammaglobulinemiaK P Lund, H Bruunsgaard, H V Marquart, et al.
Journal of Clinical Immunology|May 8, 2013
Long-term follow-up on affinity maturation and memory B-cell generation in patients with common variable immunodeficiencyV Ballegaard, H Permin, T L Katzenstein, et al.
Scandinavian Journal of Immunology|August 1, 1994
Interactions of opsonized immune complexes with whole blood cells: binding to erythrocytes restricts complex uptake by leucocyte populationsC H Nielsen, S E Svehag, H V Marquart, et al.
Immunology|March 20, 2002
CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytesC H Nielsen, H V Marquart, W M Prodinger, et al.
Complement (Basel, Switzerland)|January 1, 1988
Quantification of C3dg/Epstein-Barr virus receptors on human B cells and B cell linesJ M Rasmussen, H V Marquart, R Rask, et al.
Scandinavian Journal of Immunology|October 7, 1997
A comparative study of normal B cells and the EBV-positive Burkitt's lymphoma cell line, Raji, as activators of the complement systemH V Marquart, E H Olesen, A A Johnson, et al.
Clinical and Experimental Immunology|December 1, 1995
Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL)H V Marquart, K Grønbaek, B E Christensen, et al.
Pageof 2